Skip to main content
22 Apr 2003
UCB: First quarter Zyrtec sales in the US.
1 Apr 2003
Data analysis shows Keppra® reduced partial seizures in nearly 80 percent of elderly patients in a community-based trial.
14 Mar 2003
UCB Group : confirmation of an increase in ordinary profits of 7%.
26 Feb 2003
Celltech Group PLC (CCH) - Offer for Oxford GlycoScience
6 Feb 2003
The UCB Group in 2002: Preliminary Unaudited Profits. Record Ordinary Profits before Tax of € 494 million, an increase of 7%
31 Jan 2003
UCB closes on its acquisition of Solutia's Resins, Additives and Adhesives businesses